Inc. (MTPA) reports the effect of symptom progression in individuals with amyotrophic lateral sclerosis (ALS)

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today reported discoveries from another investigation assessing the effect of symptom progression on the